Literature DB >> 19030150

Suicidal ideation reports from pediatric trials for paroxetine and venlafaxine.

Normand Carrey1, Adil Virani Pharm.   

Abstract

Entities:  

Year:  2003        PMID： 19030150      PMCID： PMC2533826     

Source DB:  PubMed          Journal:  Can Child Adolesc Psychiatr Rev        ISSN： 1716-9119


× No keyword cloud information.
  9 in total

Review 1.  Antidepressants and suicide: risk-benefit conundrums.

Authors:  David Healy; Chris Whitaker
Journal:  J Psychiatry Neurosci       Date:  2003-09       Impact factor: 6.186

Review 2.  Suicidality with selective serotonin reuptake inhibitors: Valid claim?

Authors:  Yvon D Lapierre
Journal:  J Psychiatry Neurosci       Date:  2003-09       Impact factor: 6.186

3.  Noradrenergic and serotonergic neuroendocrine responses in prepubertal, peripubertal, and postpubertal rats pretreated with desipramine and sertraline.

Authors:  Normand J Carrey; Serdar Dursun; Robert Clements; Ken Renton; Dan Waschbusch; Frank P MacMaster
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2002-08       Impact factor: 8.829

Review 4.  Review of safety assessment methods used in pediatric psychopharmacology.

Authors:  Laurence L Greenhill; Benedetto Vitiello; Mark A Riddle; Prudence Fisher; Erin Shockey; John S March; Jerome Levine; Jane Fried; Howard Abikoff; Julie M Zito; James T McCracken; Robert L Findling; James Robinson; Thomas B Cooper; Mark Davies; Elena Varipatis; Michael J Labellarte; Lawrence Scahill; John T Walkup; Lisa Capasso; Jennifer Rosengarten
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2003-06       Impact factor: 8.829

5.  Emergence of intense suicidal preoccupation during fluoxetine treatment.

Authors:  M H Teicher; C Glod; J O Cole
Journal:  Am J Psychiatry       Date:  1990-02       Impact factor: 18.112

6.  Fenfluramine challenge in anxious children.

Authors:  Floyd R Sallee; Nandagopal S Vrindavanam; Hong Liu; Gopalan Sethuraman; Lauren Sine
Journal:  Hum Psychopharmacol       Date:  2000-12       Impact factor: 1.672

7.  Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: a replication analysis of the Food and Drug Administration Database.

Authors:  A Khan; S R Khan; R M Leventhal; W A Brown
Journal:  Int J Neuropsychopharmacol       Date:  2001-06       Impact factor: 5.176

8.  Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment.

Authors:  R A King; M A Riddle; P B Chappell; M T Hardin; G M Anderson; P Lombroso; L Scahill
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1991-03       Impact factor: 8.829

Review 9.  How can we improve the assessment of safety in child and adolescent psychopharmacology?

Authors:  Benedetto Vitiello; Mark A Riddle; Laurence L Greenhill; John S March; Jerome Levine; Russell J Schachar; Howard Abikoff; Julie M Zito; James T McCracken; John T Walkup; Robert L Findling; James Robinson; Thomas B Cooper; Mark Davies; Elena Varipatis; Michael J Labellarte; Lawrence Scahill; Lisa Capasso
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2003-06       Impact factor: 8.829
  9 in total
  1 in total

1.  Practicing child psychiatry: life in the clinic since june, 2003.

Authors:  Mary K Nixon
Journal:  Can Child Adolesc Psychiatr Rev       Date:  2004-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.